AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
16min chapter
First AI Antibody In Humans with Aulos' Aron Knickerbocker
Business Of Biotech
Peptidomimetics and Actinium-225 in Cancer Therapy
Exploring the use of peptidomimetics and actinium-225 in radiation therapy for cancer treatment, focusing on precision targeting of tumor cells while reducing toxicity. The chapter also delves into the formation of the company OLLOS, collaboration between ATP and Biologic Design, and the development of human monoclonal antibodies targeting IL-2 using AI-based antibody design. Insights on the potential role of creating antibodies against interleukin-2 to enhance tumor killing efficacy and mitigate immune suppression are discussed.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode